Inhibition of p53 expression decreases TRAIL receptor-induced apoptosis. by Anna Willms (6556340)

Resveratrol decreases the mitochondrial membrane potential (ΔΨm) and induces cytochrome <i>c</i> release from mitochondria. by José Díaz-Chávez (5648905)

Stx2 and SubAB decrease HGEC viability. by María M. Amaral (439445)

The decrease or inhibition of Hsp90 induced REST degradation. by Raúl Orozco-Díaz (7067624)

“…Cell viability was estimated after different periods (hours) by the MTT method. The viable cells’ 100% value was defined based on that obtained for non-transfected cells (<i>P</i><0.0001). …”

2-APB decreased the cytokine secretions in human DC. by Romain Félix (586765)

Receptor specific silencing decreases NGF induced apoptosis. by Alessandra Micera (294762)

“…(E) Mean Fluorescence Intensity (MFI) specific for caspACE-VAD comparing 100 ng/mL NGF and 10 ng/mL TGFβ1 effects on control-siRNA, p75^NTR siRNA and double trkA^NGFR/p75^NTR siRNA treated cells. …”

(R)-albuterol decreases cytokine mRNA levels in activated T cells by Marcela A Ferrada (41716)

“…</p><p></p> (R)-albuterol, (S)-albuterol or racemic albuterol (R + S) at a dose (10M) were added to T (EL-4) cells pre-activated with mitogens Concanavalin A (Con A, 5 μg/ml) and phorbol myristate acetate (PMA, 100 ng/ml) (CP). …”

HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

“…However, transfection of SUZ12 siRNA significantly reduced endothelial branching compared to HG+control siRNA. [NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”

Decreased levels of Fance transcription in homozygous mutant males. by Chun Fu (2553043)

CK2α decreases CLK transcription factor activity. by Áron Szabó (450885)

h-GAAP Decreases Cell Susceptibility to Extrinsic Apoptosis Pathways by Caroline Gubser (24818)

2-APB decreased the expression of maturation markers in human DC. by Romain Félix (586765)

Viability of microencapsulated FP ICCs decreased with time post-transplantation. by Vijayaganapathy Vaithilingam (390354)

“…<p>A) Fluorescent images of encapsulated FP ICCs stained with 6-CFDA for viable cells (green) and PI for non-viable cells (red) to assess viability at (A) pre-transplantation, (B) day 1, (C) day 3, (D) day 7, (E) day 14 and (F) day 21 post-transplantation. …”

Ara-C treatment caused a decrease in microglia, NG2+ progenitors, oligodendrocytes, astrocytes and T cells in the spinal cord of SOD1^G93A mice. by Jean-Nicolas Audet (326107)

PGRN decreased Dectin-2 expression on the surface of macrophages and neutrophils. by Jiayu Liu (3951515)

Cilostazol decreases OC formation and bone resorption induced by RANKL. by Ke Ke (583325)

CD11b expression and phagocytosis are decreased in non-CF macrophages treated by CFTR_inh172. by Karin Simonin-Le Jeune (464354)

The substitution F447L is adaptive for J4_S52-HVR1, while it decreases infectivity of parental J4 and J4_ΔHVR1 HCVcc. by Christina Holmboe Olesen (11154333)

DCD is strikingly decreased in HS lesions. by Margaret Coates (6058580)

“…Co-staining was performed with K77 (green), which is a marker of eccrine sweat glands. Scale bar is 100μm. …”

Diabetic wounds show increased amounts of vessel leakage and decreased pericyte coverage. by Uzoagu A. Okonkwo (8754933)